A randomized phase II trial of pre-operative docetaxel and cisplatin (DP) or docetaxel alone (D) in clinical (c-) stage IB/II nonsmall cell lung cancer (NSCLC): Initial report of Japan Clinical Oncology Group trial (JCOG 0204)

被引：0
|
作者：
Tada, H
Katoh, H
Kunitoh, H
Tsuboi, M
Asamura, H
Nagai, K
Mitsudomi, T
Koike, T
Ishizuka, N
Saijoh, N
机构：
[1] Osaka City Gen Hosp, Osaka, Japan
[2] Tokyo Med Coll, Tokyo 160, Japan
[3] Natl Canc Ctr, Tokyo 104, Japan
[4] Natl Canc Ctr E, Kashiwa, Chiba, Japan
[5] Niigata Canc Ctr, Niigata, Japan
[6] Aichi Canc Ctr, Nagoya, Aichi 464, Japan
[7] Int Med Ctr Japan, Tokyo, Japan
[8] Natl Canc Ctr E, Kashiwa, Chiba, Japan
来源：
LUNG CANCER | 2005年 / 49卷
关键词：
D O I：
10.1016/S0169-5002(05)80175-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S17 / S17
页数：1
相关论文
共 50 条
  • [1] A randomized phase II trial of pre-operative docetaxel and cisplatin (DP) or docetaxel alone (D) in clinical (c-) stage IB/II non-small cell lung cancer (NSCLC): Initial report of Japan Clinical Oncology Group trial (JCOG 0204).
    Kunitoh, H
    Kato, H
    Tsuboi, M
    Asamura, H
    Tada, H
    Nagai, K
    Mitsudomi, T
    Koike, T
    Ishizuka, N
    Saijo, N
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 650S - 650S
  • [2] A randomised phase II trial of preoperative chemotherapy of cisplatin–docetaxel or docetaxel alone for clinical stage IB/II non-small-cell lung cancer: results of a Japan Clinical Oncology Group trial (JCOG 0204)
    H Kunitoh
    H Kato
    M Tsuboi
    H Asamura
    H Tada
    K Nagai
    T Mitsudomi
    T Koike
    K Nakagawa
    Y Ichinose
    M Okada
    T Shibata
    N Saijo
    British Journal of Cancer, 2008, 99 : 852 - 857
  • [3] A randomised phase II trial of preoperative chemotherapy of cisplatin-docetaxel or docetaxel alone for clinical stage IB/II non-small-cell lung cancer: results of a Japan Clinical Oncology Group trial (JCOG 0204)
    Kunitoh, H.
    Kato, H.
    Tsuboi, M.
    Asamura, H.
    Tada, H.
    Nagai, K.
    Mitsudomi, T.
    Koike, T.
    Nakagawa, K.
    Ichinose, Y.
    Okada, M.
    Shibata, T.
    Saijo, N.
    BRITISH JOURNAL OF CANCER, 2008, 99 (06) : 852 - 857
  • [4] Five-year follow-up of preoperative chemotherapy (Cx) of docetaxel with or without cisplatin for clinical (c-) stage IB/II non-small cell lung cancer (NSCLC): Report of a Japan Clinical Oncology Group study (JCOG0204).
    Kunitoh, H.
    Tsuboi, M.
    Asamura, H.
    Tada, H.
    Nagai, K.
    Mitsudomi, T.
    Koike, T.
    Shibata, T.
    Saijo, N.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [5] A phase II trial of pre-operative chemoradiotherapy followed by surgical resection in Pancoast tumors: Report of a Japan Clinical Oncology Group trial (JCOG 9806)
    Suzuki, K
    Kunitoh, H
    Kato, H
    Tsuboi, M
    Ishizuka, N
    Asamura, H
    Ichinose, Y
    Katakami, N
    Saijo, N
    LUNG CANCER, 2005, 49 : S81 - S81
  • [6] Randomized controlled trial comparing docetaxel-cisplatin combination with weekly docetaxel alone in elderly patients with advanced non-small-cell lung cancer: Japan Clinical Oncology Group (JCOG) 0207
    Tsukada, Hiroko
    Yokoyama, Akira
    Goto, Koichi
    Shinkai, Tetsu
    Harada, Masao
    Ando, Masahiko
    Shibata, Taro
    Ohe, Yuichiro
    Tamura, Tomohide
    Saijo, Nagahiro
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2015, 45 (01) : 88 - 95
  • [7] Phase II clinical trial on docetaxel in the treatment of non-small-cell lung cancer (NSCLC).
    Chen, Y
    Zhao, Y
    Chen, Z
    Liao, M
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 708S - 708S
  • [8] A phase II trial of weekly cisplatin and docetaxel in advanced non-small cell lung cancer (NSCLC)-Final report
    Sovak, M. A.
    Guensch, L.
    Joyce, P.
    Lutzker, S. G.
    Schwartz, S.
    Shih, W. J.
    Zheng, L.
    Aisner, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [9] Adjuvant docetaxel plus cisplatin in stage I/II non-small cell lung cancer (NSCLC):: Preliminary results of a randomized phase II pilot trial of the Central European Cooperative Oncology Group (CECOG).
    Tomek, S
    End, A
    Klepetko, W
    Csiszer, E
    Csekeö, A
    Kovacs, G
    Gingrich, E
    Balint, B
    Francovszky, E
    Zielinski, CC
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 690S - 690S
  • [10] Docetaxel, cisplatin, and fluorouracil;: Docetaxel and cisplatin;: and epirubicin, cisplatin, and fluorouracil as systemic treatment for advanced gastric carcinoma:: A randomized phase II trial of the Swiss Group for Clinical Cancer Research
    Roth, Arnaud D.
    Fazio, Nicola
    Stupp, Roger
    Falk, Stephen
    Bernhard, Juerg
    Saletti, Piercarlo
    Koeberle, Dieter
    Borner, Markus M.
    Rufibach, Kaspar
    Maibach, Rudolf
    Wernli, Martin
    Leslie, Martin
    Glynne-Jones, Robert
    Widmer, Lukas
    Seymour, Matthew
    de Braud, Filippo
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (22) : 3217 - 3223
12345